Who it is for
Teams that are exploring a new research direction, partner conversation, or genomics-facing problem that needs sharper framing.
genox-site · supporting lane
Discovery and genomics-facing support.
For early conversations and partnership scoping, we help frame the problem, define the direction, and prepare a clear next step.
What we do
We turn a broad idea into a scoped memo, a clear direction, and a conversation path that is easier to progress.
What you get
A discovery brief, a framing note, and a next-step path that can be reused in partner or internal discussion.
Boundaries
We do not turn exploratory work into overpromising.
We keep the scope readable before asking for a deeper commitment.
Human review remains required for public or high-stakes claims.
Proof of work
What we have worked on.
Selected examples from genox-site engagements — discovery framing, scientific due diligence, and partnership scoping.
Biotech partner exploring an aging intervention pipeline
Longevity biomarker landscape review
Challenge
The partner needed to map the current state of longevity biomarker research before committing to a target selection process. They had a short window before a board presentation.
Approach
Structured literature brief across five longevity pillar areas (senolytics,代谢,炎症,细胞应激,端粒), competitive target landscape, and a recommended sequencing path for their pipeline.
Outcome
Board presentation supported by a 12-page evidence brief. The partner selected two targets from the first pass and commissioned a deeper analysis on one.
Output
Target landscape brief + biomarker review + sequencing recommendation
Pharmaceutical company with an established oncology franchise
Senolytic target identification (NAAA pathway)
Challenge
Exploring a shift into anti-aging indications — needed a structured brief on the NAAA pathway, its connection to senescence, and the competitive landscape before entering due diligence.
Approach
Literature review on NAAA biology and its role in senescent cell clearance, competitive landscape for NAAA-targeting approaches, and a gap analysis identifying where the client could compete.
Outcome
Delivered a decision-ready scope brief that framed the opportunity in terms of clear next steps and a differentiated positioning path. Due diligence is now in progress.
Output
NAAA target brief + competitive gap analysis + next steps
Venture capital firm evaluating a Series B target
Partner due diligence on an aging company
Challenge
An aging-focused biotech with promising preclinical data was in the due diligence window. The VC needed a structured assessment of the scientific claims, competitive position, and key risks.
Approach
Technical due diligence brief: review of published evidence, competitive landscape against three comparable programs, regulatory pathway assessment, and a risk/opportunity summary.
Outcome
The brief fed directly into the investment committee memo. The VC proceeded with a term sheet and cited the scientific assessment as a key input.
Output
Due diligence brief + risk summary + regulatory pathway assessment
Lane guide
When to use genox-site vs. biostatx
Both are supporting lanes. They serve different phases of research.
You need direction before you have data
genox-site is the lane when the question is still being shaped — you know the problem area but need to define the right research question before committing to analysis.
You are scoping a partnership or collaboration
Partner conversations move faster when both sides have a shared brief. genox-site produces a framing memo that clarifies the opportunity and the constraints.
You need to evaluate a scientific claim
Before investing, publishing, or moving forward — a genox-site brief adds an evidence-based second opinion to a scientific or strategic decision.
Quick way to decide
genox-site if you need direction before you have data — discovery, framing, partnership scoping. biostatx if you already have data and need analysis or reporting.
Route preview
Request a Paid Brief
If you're exploring a new research direction or partnership conversation, send a concise brief and we'll map the path.
What problem or research opportunity are you trying to frame?
Is this exploratory, partnership-related, or decision-driven?
What would make the next conversation useful?
24h response targetShort intake, clear next step
Submissions are routed into the Brown Biotech Notion intake hub.
Triage preview
Send a concise project brief
Share just enough context to route the request well. You'll see the route, owner, approval gate, and next action after submit.